References
- Gilroy D., Shaw C., Odling-Party E., Smee W. Detection of a vasoconstrictor factor in stroma-free haemoglobin solutions. J. Trauma. 1989; 28: 1312–16
- Toda N., Shimizu K., Ohta T. Mechanism of cerebral arterial contraction induced by blood constituents. J. Neurosurg. 1980; 53: 312–322
- White C. T., Murray A. J., Greene J. R., Smith D. J., Medina F., Makovec G. T.E.J., Bolin R. B. Toxicity of human hemoglobin solution infused into rabbits. J. Lab. Clin. Med. 1986; 108: 121–131
- Macdonald V. W., Winslow R. M., Marini M. A., Klinker M. T. Coronary vasoconstriction activity of purified and modified human hemoglobin. Biomat. Art. Cells Art. Org. 1990; 18: 263–282
- Vogel W. M., Dennis R. C., Cassidy G., Apstein C. S., Valeri C. R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 1986; 251: H413–H420
- Martin W., Smith J. A., White D. G. The mechanism by which hemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br. J. Pharmacol. 1986; 89: 563–571
- Palmer R. M.J., Ferrige A. G., Monacada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–526
- Simoni J., Feola M., Canizaro P. C. Generation of free oxygen radicals and the toxicity of hemoglobin solutions. Biomat. An. Cells Art. Org. 1990; 18(2)189–202
- Sadrzadeh S. M.H., Graf E., Panter S. S., Hallaway P. E., Eaton J. W. Hemoglobin: A biological Fenton reagent. J. Biol. Chem. 1984; 259: 14354–56
- Rubanyi G. M., Vanhoutte P. M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 1986; 250: H822–H827
- Macdonald V. M., Winslow R. M. Oxygen delivery and myocardial function in rabbit hearts perfused with cell-free hemoglobin. J. Appl. Physiol. 1992; 72(2)476–483
- Snyder S. R., Welty E. V., Walder R. Y., Williams L. A., Walder J. A. 88HbXL99α: a hemoglobin derivative that is crosslinked between the α subunits is useful as a blood substitute. Proc. Natl. Acad. Sci. USA 1987; 84: 7280–7284
- Amezcua J. L., Palmer R. M.J., de Souza B. M., Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol. 1989; 97: 1119–1124
- Kelm M., Schrader J. Control of coronary vascular tone by nitric oxide. Cir. Res. 1990; 66: 1561–1575
- Kelm M., Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur. J. Pharmacol. 1988; 155: 313–316
- Lamontagne D., Pohl U., Busse R. N G-Nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor. Pflugers Arch. 1991; 418: 226–270
- Martin W., Villani G. M., Jothianandan D., Furchgott F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 1985; 232: 708–716
- Amezcua J. L., Dusting G. J., Palmer R. M.J., Moncada S. Acetylcholine induces vasodilation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. 1988; 95: 830–834
- Furchgott R. F., Zawadski J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376
- Misra H. P., Fridovich I. The generation of superoxide radical during the autoxidation of hemoglobin. J. Biol. Chem. 1972; 247: 6960–62
- Halliwell B., Gutteridge J. M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 1984; 219: 1–14
- Stewart D. J., Pohl U., Bassenge E. Free radicals inhibit endothelium-dependent dilation in the coronary resistance bed. Am. J. Physiol. 1988; 255: H765–H769